Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

RBC Capital Says This Dystrophy Stock 'Is Worth A Look'

RBC Capital says Edgewise Therapeutics Inc's (NASDAQ:EWTX) interim results from the ARCH study of EDG-5506 in Becker Muscular Dystrophy (BMD) improve reward/risk into October functional readout at 15 mg, which can help further de-risk the asset into the phase 2 BMD and Duchenne muscular dystrophy (DMD) studies. The analysts believe stable patient NSAAs in October…

Benzinga

Why Shares Of Ocean Bio-Chem Rose 117% On Wednesday

Ocean Bio-Chem Inc. (NASDAQ: OBCI) shares are trading higher after the company announced it will be acquired by OneWater Marine for $13.08 per share in an all-cash transaction valued at approximately $125 million.

Benzinga

Lincoln Tech Launches Podcast Series On Job Opportunities

Lincoln Educational Services Corp (NASDAQ:LINC) has launched a podcast series to highlight career opportunities in industries that need skilled employees. Lincoln Tech's Skills @ Work podcasts will help educate listeners about skills needed to succeed in career fields that are often ignored. The podcasts are available on major delivery channels, and each episode…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

HC Wainwright Believes This Cancer-Focused Stock Is Undervalued At $550M

HC Wainwright initiated coverage of Celularity Inc (NASDAQ:CELU) with a Buy rating and a price target of $15. HC Wainwright believes Celularity's current valuation of approximately $550 million is undervalued considering the upside potential of the company's platform and provides an attractive entry point for long-term investors. The analyst wrote that the company had…

Benzinga

BridgeBio Pharma Posts Promising Data From Gene Therapy Trial In Ultra-Rare Disease

BridgeBio Pharma Inc (NASDAQ:BBIO) announced promising pharmacodynamic data from the first two participants dosed in CANaspire Phase 1/2 trial of BBP-812, gene therapy for Canavan disease. Canavan disease is an ultra-rare inherited disorder that damages the ability of nerve cells (neurons) in the brain to send and receive messages. Data from the first…

Benzinga

10 Information Technology Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Benzinga

Warner Music Group CEO Plans To Step Down Next Year

Warner Music Group Corp (NASDAQ:WMG) disclosed planning for the succession of CEO and director Stephen Cooper. WMG expects the transition to happen by the end of 2023. Cooper has served as CEO since 2011. He will continue to serve as CEO and director until his successor is appointed. WMG reported second-quarter FY22 revenue growth of…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Apple Patents A Notebook Unlike Anything We've Seen Before

Apple Inc. (NASDAQ: AAPL) has been brainstorming some high-tech changes for its Macbook, according to a new patent.

Benzinga

Vaccitech's Vaccine Induced Sustained Reductions In Hepatitis B Associated Antigens

Vaccitech plc (NASDAQ:VACC) announced an update to the interim analysis of safety and efficacy data from the HBV002 study evaluating ChAdOx1-HBV and MVA-HBV vaccines (VTP-300) in chronic HBV patients who are virally suppressed with oral anti-viral therapies. In the VTP-300 monotherapy group, meaningful and durable reductions of HBsAg were seen in all three patients with…

Benzinga

BoE Explains Why Crypto Crash Survivors Could Become Future Amazons, eBays

Bank of England Deputy Governor Jon Cunliffe sees a possibility for crypto meltdown survivors to become the future technology companies, rivaling Amazon.com Inc (NASDAQ:AMZN) and eBay Inc (NASDAQ: EBAY), Bloomberg reports from a Zurich forum. Cunliffe drew parallels between the meltdown wiping more than $1 trillion off the value of Bitcoin and other cryptocurrencies to the dot-com collapse at…

Benzinga

Insiders Buy More Than $21M Of 3 Penny Stocks

U.S. stocks traded slightly higher on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Benzinga

Digital Ally Bags Notable Order For Body-Worn Cameras

Digital Ally, Inc. (NASDAQ:DGLY) has received a notable order from the Wyandotte County Sheriff's Office (KS) to bolster its deployment of body-worn cameras. The financial terms were not disclosed. The Wyandotte County Sheriff's Office ordered an additional 23 FirstVu Pro body-worn cameras and 23 EVO HDs, continuing the recent expansion to their focus…

Benzinga

Expert Ratings for GoodRx Holdings

Analysts have provided the following ratings for GoodRx Holdings (NASDAQ:GDRX) within the last quarter:

Benzinga

4 Analysts Have This to Say About Phillips Edison

Within the last quarter, Phillips Edison (NASDAQ:PECO) has observed the following analyst ratings:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What Are Whales Doing With Enphase Energy

A whale with a lot of money to spend has taken a noticeably bearish stance on Enphase Energy. Looking at options history for Enphase Energy (NASDAQ:ENPH) we detected 20 strange trades.

Benzinga

How Is The Market Feeling About PayPal Holdings?

PayPal Holdings's (NASDAQ:PYPL) short percent of float has risen 10.63% since its last report. The company recently reported that it has 26.53 million shares sold short, which is 2.29% of all regular shares that are available for trading.

Benzinga

Looking At Pinduoduo's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on Pinduoduo. Looking at options history for Pinduoduo (NASDAQ:PDD) we detected 19 strange trades.

Benzinga

eBay Acquires Leading NFT Marketplace: What You Need To Know

Ecommerce giant eBay Inc (NASDAQ: EBAY) announced that it has acquired NFT marketplace KnownOrigin for an undisclosed sum.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

10 Of The Highest Volume Options Contracts On Wednesday: Ford, Tesla, Amazon And More

Trading volume is critical for small-window options traders, as it gives insight into how many contracts have been purchased on an options strike. A high-volume option can provide liquidity, giving investors a better opportunity to sell their contracts over those with lower volumes.

Benzinga

U.S. Stocks Turn Higher; Athira Pharma Shares Plummet

U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 30 points on Wednesday.

Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.

Benzinga

Advanced Micro Devices Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Advanced Micro Devices (NASDAQ:AMD). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Baird Maintains Neutral Rating for GoodRx Holdings: Here's What You Need To Know

Baird has decided to maintain its Neutral rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $7.00 to $6.00. Shares of GoodRx Holdings are trading up 6.94% over the last 24 hours, at $6.32 per share. A move to $6.00 would account for a 5.06% decline from the…

Benzinga

Chardan Capital Maintains Buy Rating for CRISPR Therapeutics: Here's What You Need To Know

Chardan Capital has decided to maintain its Buy rating of CRISPR Therapeutics (NASDAQ:CRSP) and lower its price target from $168.00 to $164.00. Shares of CRISPR Therapeutics are trading down 8.24% over the last 24 hours, at $59.34 per share.

Benzinga

Credit Suisse Maintains Outperform Rating for PayPal Holdings: Here's What You Need To Know

Credit Suisse has decided to maintain its Outperform rating of PayPal Holdings (NASDAQ:PYPL) and lower its price target from $100.00 to $95.00. Shares of PayPal Holdings are trading up 1.2% over the last 24 hours, at $73.24 per share.

1 … 429 430 431 432

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.